Prostate cancer screenings could save lives but experts warn of major risks Prostate cancer is the most common cancer among men in the UK, with more than 64,000 diagnoses anually The Independent UK · Oct 30, 2025
Study shows prostate cancer screening can ‘reduce deaths’ as UK scheme assessed Experts called for a ‘targeted’ screening approach to prevent overdiagnosis. Evening Standard · Oct 30, 2025
Prostate cancer drug that can halve death risk to be offered to thousands in England At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects The Guardian - UK · Oct 23, 2025
Prostate cancer sufferers in ‘postcode lottery’ to get new drug, says charity It comes as concerns were raised that a new drug approved for NHS use will not be given to eligible patients. Evening Standard · Oct 23, 2025
New ‘gentler’ treatment for prostate cancer gets green light but not all men will have access to it It comes as concerns were raised that a new drug approved for NHS use will not be given to eligible patients The Independent UK · Oct 23, 2025
UK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment The U.K.’s National Institute for Health and Care Excellence (NICE) is recommending a treatment from a firm jointly owned by GSK Plc (NYSE:GSK), Pfizer Inc (NYSE:PFE) and Shionogi Inc. Benzinga · Oct 17, 2025
England and Wales to get long-lasting HIV prevention jab for first time The drug, known as cabotegravir, must be administered every two months. Euronews · Oct 17, 2025
‘Gamechanging’ HIV prevention jab to be approved for England and Wales Long-acting injection offers alternative to daily pills taken to protect against the virus The Guardian - UK · Oct 17, 2025
‘Game-changing’ HIV jab to be offered in England and Wales The rollout is expected to begin around three months after Nice publishes its final guidance later this year The Independent UK · Oct 17, 2025
‘Game-changing’ HIV prevention jab to be offered in England and Wales The National Institute for Health and Care Excellence recommended the injection for people at risk of HIV who are unable to take oral PrEP. Evening Standard · Oct 17, 2025
Brain cancer patients left ‘devastated’ as new drug is rejected for NHS use Patients who have taken the drug in clinical trials report remarkable results, including their tumours shrinking The Independent UK · Oct 15, 2025
Patients with brain cancer express disappointment after drug rejected for NHS Patients who have taken the drug in clinical trials report remarkable results, including their tumours shrinking. Evening Standard · Oct 15, 2025
Almost 300,000 protest against pushing up NHS drug prices Campaign group 38 Degrees said the Government ‘must reject demands for higher prices for vital NHS medicine’. The Independent UK · Oct 13, 2025
‘It May Not Be So Easy’—Marsch Copes With Canada Injuries Ahead of 2026 World Cup Canada will be without three key defenders for the second straight window as the World Cup nears. Sports Illustrated · Oct 9, 2025
The Independent UK · Oct 8, 2025 Researchers warn doctors could be ‘overtesting’ for prostate cancer PSA testing remains controversial because it can lead to healthy men being diagnosed and treated unnecessarily
The Independent UK · Oct 8, 2025 Trump pressure to hike UK drug prices could cost NHS billions, experts warn Anew deal will only trigger further increased price demands and make healthcare in the UK more expensive, say experts
The Guardian - UK · Oct 8, 2025 NHS could pay 25% more for medicines under plan to end row with drugmakers and Trump UK ministers preparing to raise payments to end standoff with pharma industry, cited as reason for firms axing British investments
Evening Standard · Oct 8, 2025 Change to NHS drug analysis on the table to stave off US tariffs – reports It is understood plans have been outlined to increase the amount the health service pays for medicines.
Evening Standard · Oct 1, 2025 Will Paul Pogba make his return to football against Tottenham after injury nightmare and ban? The former Manchester United and Juventus star has suffered a setback on his bid return to action
The Conversation · Sep 30, 2025 The UK must invest in medicines – but not at any price The UK’s science minister, Sir Patrick Vallance, has sounded the alarm over the country’s declining investment in medicines. He warned that the NHS risks losing out on important treatments and the country could lose its place at the cutting edge of medical research if spending does not recover. It comes…
International Business Times · Sep 25, 2025 Forest Denied Winning European Return By Antony, Roma Down Nice Antony's late goal denied Nottingham Forest a winning return to European football as Real Betis grabbed a 2-2 draw in their Europa League opener on Wednesday, while Roma won at Nice.
The Independent UK · Sep 22, 2025 NHS risks missing ‘new era’ of Alzheimer’s treatment without major reforms, experts warn A new ‘medical revolution’ in treating Alzheimer’s disease is coming, a leading professor says
Evening Standard · Sep 22, 2025 NHS ‘not ready’ for new era of Alzheimer’s diagnosis and treatment, experts say It comes as a series of papers by 40 experts said a ‘concerted societal effort’ is needed to ensure patients benefit fully from scientific advances.
The Guardian - UK · Sep 18, 2025 NHS drug pricing is all about the art of the deal Letter: Better negotiation with big pharma could ease the process, writes Andrew Dillon, in response to an article by Polly Toynbee about Donald Trump’s complaints about NHS pricing
The Guardian - UK · Sep 16, 2025 Who benefits if NHS drug prices soar? Donald Trump and big pharma. Just one more way he’s menacing Britain The NHS needs cheap drugs, and our economy needs a thriving pharma industry. The president threatens both – no wonder Labour is grovelling to him, says Guardian columnist Polly Toynbee